Blue Whale Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108M Buy
89,985
+1,807
+2% +$1.85M 3.42% 10
2026
Q1
$81.1M Buy
88,178
+30,300
+52% +$30.7M 3.86% 10
2025
Q4
$62.2M Buy
+57,878
New +$55.3M 3.19% 12

Other funds holding LLY

Blue Whale Capital's LLY Position: Q2 2026 in Review

Blue Whale Capital increased its Eli Lilly (LLY) stake by 2% in Q2 2026, buying an estimated $1.85M and bringing the position to 89,985 shares worth $108M. The position accounts for 3.42% of the portfolio, ranked #10.

Blue Whale Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Blue Whale Capital held 89,985 shares of Eli Lilly worth $108M as of Q2 2026.
  • Blue Whale Capital bought 1,807 Eli Lilly shares in Q2 2026, an estimated $1.85M.
  • Eli Lilly made up 3.42% of Blue Whale Capital's portfolio in Q2 2026, its #10 holding.
  • Blue Whale Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Blue Whale Capital's 13F filing for Q2 2026, filed 13 Aug 2026.